Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital

References

• Hibbett DS, Binder M, Bischoff JF, . A higher-level phylogenetic classification of the fungi. Mycol Res 2007; 11: 509–547.
   Google Scholar
• Chayakulkeeree M, Ghannoum M, Perfect J. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25: 215–229.
   PubMed Web of Science ®Google Scholar
• Bouza E, Muñoz P, Guinea J. Mucormycosis: an emerging disease?. Clin Microbiol Infect 2006; 12(Suppl. 7):7–23.
   Google Scholar
• Maertens J, Demuynck H, Verbeken E, . Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999; 24: 307–312.
   PubMed Web of Science ®Google Scholar
• Richardson M, Koukila-Kähkölä P, Shankland G,. Rhizopus, Rhizomucor, Absidia , and other agents of systemic and subcutaneous Zygomycoses. Murray P, Baron E, Jorgensen J, Pfaller M, Yolken R, Manual of Clinical Microbiology 8th edn. Washington, DC: ASM Press, 2003: 1761–1780.
   Google Scholar
• Roden M, Zaoutis T, Buchanan W, . Epidemiology and outcome of Zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634–653.
   PubMed Web of Science ®Google Scholar
• Tobón A, Arango M, Fernández D, Restrepo A. Mucormycosis (Zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clin Infect Dis 2003; 36: 1488–1491.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis D, Lionakis M, Lewis R, . Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. JID 2005; 191: 1350–1360.
   PubMed Web of Science ®Google Scholar
• Greenberg R, Scott L, Vaughn H, Ribes J. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 2004; 17: 517–525.
   PubMed Web of Science ®Google Scholar
• Marty F, Cosimi L. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. New Engl J Med 2004; 350: 950–952.
   PubMed Web of Science ®Google Scholar
• Siwek G, Dodgson K, de Magalhaes-Siverman M, . Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584–587.
   PubMed Web of Science ®Google Scholar
• Oren I. Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia. Clin Infect Dis 2005; 40: 770–771.
   PubMed Web of Science ®Google Scholar
• Vigouroux S, Morin O, Moreau P, . Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis 2005; 40: e35–e37.
   PubMed Web of Science ®Google Scholar
• Kauffman C. Zygomycosis: reemergence of an old pathogen. Clin Infect Dis 2004; 39: 588–590.
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex J, de Pauw B, . Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7–14.
   PubMed Web of Science ®Google Scholar
• Safdar A, O’Brien S, Kouri I. Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosis. Bone Marrow Transplantation 2004;34: 467.
   PubMed Web of Science ®Google Scholar
• Marr K, Carter R, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:909–917.
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Meletiadis J, Mouton J, . In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003;51:45–52.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Das A, Sharma A, . Ten years’ experience in zygomycosis at a tertiary care center in India. J Infect 2001;42:261–266.
   PubMed Web of Science ®Google Scholar
• Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases? Leukemia Lymphoma 2004;45: 1351–1360.
   PubMed Web of Science ®Google Scholar
• Petrikkos G, Skiada A, Sambatakou H, . Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 2003;22:753–756.
   PubMed Web of Science ®Google Scholar
• Greenberg R, Mullane K, van Burik J-A, . Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006;50:126–133.
   PubMed Web of Science ®Google Scholar
• Lehrer R, Howard D, Sypherd P, . Mucormycosis. Arch Intern Med 1980;93:93–108.
   Google Scholar
• Pagano L, Offdani M, Fianchi L, . Mucormycosis in hematologic patients. Haematologica 2004;89:207–214.
   PubMed Web of Science ®Google Scholar
• Ribes J, Vanover-Sams C, Baker D. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236–301.
   PubMed Web of Science ®Google Scholar
• Bigby T, Serota M, Tierny L, Matthay M. Clinical spectrum of pulmonary mucormycosis. Chest 1986;89:435–439.
   PubMed Web of Science ®Google Scholar
• Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005;41:60–66.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis D, Wessel V, Bodey G, Rolston K. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000: 30:851–856.
   PubMed Web of Science ®Google Scholar
• Cummings J, Jamison G, Boudreaux J, . Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn Micr Infec Dis 2007;59:113–115.
   PubMed Web of Science ®Google Scholar
• Swanink C, Meis J, Rijs A, Donnelly J, Verweij P. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997;35:257–260.
   PubMed Web of Science ®Google Scholar
• Sims C, Ostrosky-Zeichner L. Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center. Arch Med Res 2007;38:90–93.
   PubMed Web of Science ®Google Scholar